In this work, we contend with such challenges by leveraging single-nucleus DNA-sequencing and the presence of somatic PIK3CA mutations in a fraction of the lesional cells to specifically establish somatic LOH as a mechanism for biallelic inactivation in CCMs. This evidence concerns the gene PIK3CA and cerebrocostomandibular syndrome.